StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > POOR OLE TRIPPIN

<< Previous

Bullboard Posts

Next >>

Comment by capebretongirlon Mar 23, 2021 2:35pm

152 Views

Post# 32859419

RE:RE:POOR OLE TRIPPIN

Bucky86 wrote: It's obvious everyone is a little anxious and wound up here.... at the same time CBG you haven't responded to anything about oncore, 30 million in revenue and the massive 7-10 day partnership reveal...this company has been massively missing targets. So while trippin does ramble on a bit, some of this is justified

Why would I provide a lengthy explanation too you on old old news - that repetitive discussion would be about as exciting as watching water run from a tap - you are the only one fixated on a missed overly optimistic projection and disregarding the reality of confidentiality clauses in contracts.............

<< Previous

Bullboard Posts

Next >>

From now on, dynaCERT instead of Bitcoin or NVIDIA?